Konstantina Kalyvianaki
Overview
Explore the profile of Konstantina Kalyvianaki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
137
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Kalyvianaki K, Malamos P, Mastrodimou N, Manoura-Zonou I, Vamvoukaki R, Notas G, et al.
NPJ Sci Food
. 2020 Dec;
4(1):20.
PMID: 33298942
The importance of herbal extracts on health, which was initially based on ethnopharmacological and traditional knowledge, becomes increasingly well documented by numerous experimental and intervention studies. The daily use of...
12.
Panagiotopoulos A, Papachristofi C, Kalyvianaki K, Malamos P, Theodoropoulos P, Notas G, et al.
Pharmacol Res Perspect
. 2020 Jul;
8(4):e00600.
PMID: 32662237
Drug development is an arduous procedure, necessitating testing the interaction of a large number of potential candidates with potential interacting (macro)molecules. Therefore, any method which could provide an initial screening...
13.
Kalyvianaki K, Panagiotopoulos A, Malamos P, Moustou E, Tzardi M, Stathopoulos E, et al.
Steroids
. 2019 Feb;
142:100-108.
PMID: 30707908
Accumulating evidence during the last decades revealed that androgens exert membrane-initiated actions leading to the modulation of significant cellular processes, important for cancer cell growth and metastasis (including prostate and...
14.
Polioudaki H, Chantziou A, Kalyvianaki K, Malamos P, Notas G, Mavroudis D, et al.
Cell Oncol (Dordr)
. 2019 Jan;
42(2):237-242.
PMID: 30680705
Background: The levels of expression and membrane localization of programmed cell death ligand 1 (PD-L1), an immune checkpoint type I transmembrane glycoprotein, are related to the clinical response of anti-PD-L1/PD-1...
15.
Pelekanou V, Notas G, Athanasouli P, Alexakis K, Kiagiadaki F, Peroulis N, et al.
Front Oncol
. 2018 Aug;
8:301.
PMID: 30131941
Recent advances in cancer immunology revealed immune-related properties of cancer cells as novel promising therapeutic targets. The two TNF superfamily members, APRIL (TNFSF13), and BAFF (TNFSF13B), which are type II...
16.
Panagiotopoulos A, Kalyvianaki K, Castanas E, Kampa M
Cancer Metastasis Rev
. 2018 Aug;
37(2-3):237-243.
PMID: 30078159
Many epidemiological studies revealed an association of dietary consumption of fatty acids and prostate cancer. Linoleic acid and alpha-linolenic acid and their derivatives such as arachidonic acid and eicosapentanoic acid...
17.
Gebhart V, Caldwell J, Rodewald A, Kalyvianaki K, Kampa M, Jirikowski G
Steroids
. 2018 Jul;
142:94-99.
PMID: 30030052
Estrogens exert a critical influence on neuronal tissues and cells. As demonstrated in many clinical studies, estrogens are neuroprotective to the extent that they improve prognosis for women with neurodegenerative...
18.
Kalyvianaki K, Gebhart V, Peroulis N, Panagiotopoulou C, Kiagiadaki F, Pediaditakis I, et al.
Sci Rep
. 2017 Mar;
7:44418.
PMID: 28290516
Accumulating evidence during the last decades revealed that androgen can exert membrane initiated actions that involve signaling via specific kinases and the modulation of significant cellular processes, important for prostate...